COMMUNIQUÉS West-GlobeNewswire

Recro Pharma Announces Key Sales Team Additions
02/02/2018
MALVERN, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]
miRagen Therapeutics Presents New Data from Phase 1 Clinical Trial of MRG-106 in Mycosis Fungoides at the T-Cell Lymphoma Forum
02/02/2018
90% of evaluable patients show clinical improvement in the ongoing Phase 1 clinical trial of MRG-106. 80% of patients treated with 300 mg IV infusion, the anticipated Phase 2 clinical trial dose, demonstrated an [...]
Aixplorer® and Aixplorer® Ultimate Ultrasound Diagnostic Systems Receive 510(k) Clearance for Clinical Management of Liver Disease
02/02/2018
AIX-EN-PROVENCE, France, Feb. 02, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814), a company specializing in ultrasound medical imaging, announced today that the Aixplorer® and Aixplorer® [...]
TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of Ublituximab (TG-1101) in Patients with Multiple Sclerosis at the Third Annual ACTRIMS Forum 2018
02/02/2018
100% reduction of T1 Gd-enhancing lesions at week 24 (n=38) 99% median B-cell depletion was observed at week 4 and maintained at week 24 (n=40) TG-1101 was well tolerated across all patients including those receiving 1 [...]
Outcome of Infant Bacterial Therapeutics' rights issue
02/02/2018
Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, Singapore, the United States or in any other jurisdiction where such distribution of this press [...]
Aquinox to Present at LEERINK Partners 7th Annual Global Healthcare Conference
02/02/2018
VANCOUVER, British Columbia, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to [...]
Athersys Enters Into New $100 Million Equity Facility with Aspire Capital
02/02/2018
Provides access to capital to support ongoing business and development objectives CLEVELAND, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX ) and Aspire Capital Fund, LLC (“Aspire Capital”) announced [...]
OraSure Technologies Appoints Aradhana Sarin, M.D. to Board of Directors
02/02/2018
BETHLEHEM, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced the appointment of Dr. Aradhana [...]
OpGen Announces Pricing of $12 Million Upsized Public Offering
02/02/2018
GAITHERSBURG, Md., Feb. 02, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announces the pricing of a public offering of an aggregate of 3,692,307 units. Each unit is comprised of one share of common stock (or [...]
Announcement by Irina Maligina and Nika Saveljeva, Daughters of Late Valerijs Maligins
02/02/2018
Olaine, 2018-02-02 08:57 CET (GLOBE NEWSWIRE) -- In relation to the sudden passing away of our father Valerijs Maligins and his will to share his inheritance equally among all three of his daughters, we would like to [...]
Solon Eiendom ASA : Primary insider notification
02/02/2018
(Oslo, Norway, February 01, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) has today bought 45.000 shares in Solon Eiendom ASA at a price of NOK 21.8681. Following [...]
Solon Eiendom ASA : Primary insider notification
02/02/2018
(Oslo, Norway, February 01, 2018) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 45,000 shares in Solon Eiendom ASA at a price of NOK 21.8681 per [...]
Solon Eiendom ASA : Primary insider notification
02/02/2018
(Oslo, Norway, February 01, 2018) Solon Eiendom ASA Board Member Edvin Austbø (through his wholly owned company Alden AS) has today bought 45,000 shares in Solon Eiendom ASA at a price of NOK 21.8681 per share. [...]
Solon Eiendom ASA : Primary insider notification
02/02/2018
(Oslo, Norway, February 01, 2018) Solon Eiendom ASA CEO Andreas Martinussen (through his wholly owned company John Galt AS) has today bought 50,000 shares in Solon Eiendom ASA at a price of NOK 21.8681 per share. [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
02/02/2018
REGULATED INFORMATION GHENT, Belgium, 2 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Van Leeuwenhoeck Issues Equity Research Note Highlighting Value of Recent Indivior Strategic Partnership on GABAB PAM
02/02/2018
Geneva, Switzerland, 2 February 2018 - Addex Therapeutics (SIX: ADXN) announced today that the independent life science research company Van Leeuwenhoeck has issued an equity research note highlighting the value of the [...]
Targovax ASA: Exercise price of options
02/02/2018
With reference to the Stock exchange notification issued 1 February 2018 regarding options to employees: The exercise price of the granted options is NOK 17.17. The exercise price is equal to the volume weighted average [...]
INSYS Therapeutics Addresses New York Attorney General’s Complaint
02/02/2018
PHOENIX, Feb. 01, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today released the [...]
Kane Biotech Provides Additional Information Regarding Engagement of Investor Relations Counsel
02/02/2018
WINNIPEG, Manitoba, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce additional information regarding its engagement of Edison [...]

Pages